Scientists have developed a drug compound that may freeze cancer cells and kill them, thus keeping them from spreading throughout the body.
The study found that the compound named KBU2046 is highly effective and can slow down cell motility in the cancers of breast, prostate, colon and lungs in the in vitro model.
"Movement is key: the difference is black and white, night and day. If cancer cells spread throughout your body, they will take your life. We can treat it, but it will take your life," said Raymond Bergan from Oregon Health and Science University (OHSU) in the US.
"We used chemistry to probe biology to give us a perfect drug that would only inhibit the movement of cancer cells and wouldn't do anything else. That basic change in logic lead us to do everything we did."
In the study, published in the journal Nature Communications, the team used a mouse model to test the drug.
"We started off with a chemical that stopped cells from moving, then we increasingly refined that chemical until it did a perfect job of stopping the cells with no side effects," Bergan said.
The team found that the key to this drug was engaging the heat shock proteins -- the "cleaners" of a cell.
"The way the drug works is that it binds to these cleaner proteins to stop cell movement, but it has no other effect on those proteins," Bergan said.
"Our eventual goal is to be able to say to a woman with breast cancer: here, take this pill and your cancer won't spread throughout your body. The same thing for patients with prostate, lung, and colon cancer."
The team will now move this forward as a therapy to test in humans.
--IANS
sh/rt/him/vd
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
